-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$16,430
Evelo Biosciences, Inc. Insider Transactions
Evelo Biosciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Bodmer Mark
CSO, President of R&D |
Sell | 3,163 @ $0.33 | $1,044 | 25,732 | 11/08/2023 | 11/08/2023 | |
|
McHale Duncan
Chief Medical Officer |
Sell | 3,103 @ $0.33 | $1,024 | 16,984 | 11/08/2023 | 11/08/2023 | |
|
GILL SIMBA
CEO |
Sell | 172 @ $0.33 | $57 | 17,758 | 11/08/2023 | 11/08/2023 | |
|
Thorell Marella
CFO |
Sell | 1,811 @ $0.33 | $598 | 22,259 | 11/08/2023 | 11/08/2023 | |
|
Bodmer Mark
CSO, President of R&D |
Sell | 6,854 @ $0.33 | $2,262 | 22,270 | 11/02/2023 | 11/03/2023 | |
|
McHale Duncan
Chief Medical Officer |
Sell | 6,854 @ $0.33 | $2,262 | 13,587 | 11/02/2023 | 11/03/2023 | |
|
Thorell Marella
CFO |
Sell | 3,999 @ $0.33 | $1,320 | 17,570 | 11/02/2023 | 11/03/2023 | |
|
GILL SIMBA
CEO |
Sell | 1,996 @ $3.94 | $7,864 | 16,758 | 09/28/2023 | 09/29/2023 | |
|
Bodmer Mark
CSO, President of R&D |
Sell | 3,128 @ $9.51 | $29,747 | 16,624 | 08/08/2023 | 08/09/2023 | |
|
GILL SIMBA
CEO |
Sell | 342 @ $9.51 | $3,252 | 3,754 | 08/08/2023 | 08/09/2023 | |
|
McHale Duncan
Chief Medical Officer |
Sell | 3,434 @ $9.51 | $32,657 | 7,941 | 08/08/2023 | 08/09/2023 | |
|
Thorell Marella
CFO |
Sell | 2,004 @ $9.51 | $19,058 | 9,069 | 08/08/2023 | 08/09/2023 | |
|
Flagship Ventures Fund IV General Partner LLC
10 percent owner |
Buy | 3,246,753 @ $2.31 | $7.50 M | 3,931,685 | 07/11/2023 | 07/13/2023 | |
|
Flagship Ventures Fund IV General Partner LLC
10 percent owner |
Buy | 1,082,251 @ $2.31 | $2.50 M | 1,461,795 | 07/11/2023 | 07/13/2023 | |
|
Bodmer Mark
CSO, President of R&D |
Sell | 22,571 @ $0.14 | $3,201 | 262,557 | 05/23/2023 | 06/12/2023 | |
|
McHale Duncan
Chief Medical Officer |
Sell | 66,730 @ $0.13 | $8,375 | 97,516 | 05/08/2023 | 05/10/2023 | |
|
Bodmer Mark
CSO, President of R&D |
Sell | 68,014 @ $0.13 | $8,536 | 285,128 | 05/08/2023 | 05/10/2023 | |
|
Thorell Marella
CFO |
Sell | 38,531 @ $0.13 | $4,836 | 91,469 | 05/08/2023 | 05/10/2023 | |
|
GILL SIMBA
CEO |
Sell | 3,537 @ $0.13 | $444 | 58,512 | 05/08/2023 | 05/10/2023 | |
|
CARRIERE STEPHEN J
Principal Accounting Officer |
Sell | 151 @ $1.06 | $160 | 203 | 01/23/2023 | 01/23/2023 |
Evelo Biosciences, Inc. Frequently Asked Questions
-
Who is on Evelo Biosciences, Inc.'s Insider Roster?
The list of insiders at Evelo Biosciences, Inc. includes GILL SIMBA, Thorell Marella, McHale Duncan, Bodmer Mark.
-
How much insider selling is happening at Evelo Biosciences, Inc.?
Insiders have sold a total of 27,952 Evelo Biosciences, Inc. shares in the last 12 months for a total of 16,430 sold.
-
Which Evelo Biosciences, Inc. insiders have been selling company stock?
The following insiders have sold Evelo Biosciences, Inc. shares in the last 12 months: GILL SIMBA ($7,921), Thorell Marella ($1,917), McHale Duncan ($3,286), Bodmer Mark ($3,306),